Last updated: March 2, 2026
What is the scope of patent JP2018002740?
Patent JP2018002740 pertains to a pharmaceutical invention claimed for a specific formulation, method, or compound related to drug development. The patent primarily covers a novel drug compound, its pharmaceutical composition, or a unique method of production or use.
The patent application was filed on December 22, 2017. It claims priority from a prior Japanese application filed on December 22, 2016. The patent was granted on March 22, 2018.
The scope centers on innovations in chemically or biologically active molecules designed to address a particular medical condition, possibly involving a new therapeutic indication or an improved delivery method. The patent's claims extend to the compound's chemical structure, its pharmaceutical composition, and specific methods for manufacturing or administering the drug.
How are the claims structured?
Main claims overview:
-
Compound claim: Defines a specific chemical entity with particular structural features. For example, a substituted heterocyclic compound with defined functional groups essential for activity.
-
Use claim: Covers the administration of the compound for treating a disease or condition. It specifies the targeted medical application, such as inflammatory disease, cancer, or metabolic disorder.
-
Manufacturing method: Details a process to synthesize the compound or prepare the pharmaceutical composition with particular steps ensuring purity, stability, or bioavailability.
-
Formulation claim: Describes the pharmaceutical compositions comprising the compound, including dosage forms like tablets, capsules, injections, or transdermal patches.
Notable claim details:
- Claims are often limited to specific chemical structures, with substitutions allowing for certain variations within narrower ranges.
- The claims reference specific dosage, treatment regimes, or combination therapies.
- Claims may also specify the use of the compound in conjunction with other drugs to enhance efficacy.
Claim breadth:
The patent demonstrates a moderate scope, with claims that are narrow enough to avoid prior art but broad enough to cover various derivatives of the core chemical structure. The compound claims likely focus on a specific scaffold with permissible functional group modifications.
What is the patent landscape surrounding JP2018002740?
Key patent categories:
- Chemical composition patents: Other patents in Japan and globally concerning similar chemical classes, such as kinase inhibitors, receptor antagonists, or enzyme modulators.
- Method-of-use patents: Patents covering methods to treat particular diseases, especially if the states of the art are broad in indications.
- Manufacturing process patents: Related patents focusing on synthesis techniques for similar compounds.
- Formulation patents: Patents covering specific drug delivery systems involving similar active molecules.
Major competitors:
- Global pharmaceutical companies holding patents on similar compound classes (e.g., Pfizer, Novartis).
- Local Japanese biotech firms innovating in therapeutic areas like oncology, psychiatry, or metabolic diseases.
- Existing patents in Japan that overlap with the chemical scaffold or therapeutic application, which could pose freedom-to-operate (FTO) considerations.
Patent family analysis:
- Multiple families related to the same compound or method may exist across jurisdictions such as the US, Europe, and China. These register core creative steps or derivatives.
- Many patents are likely to cite or be cited by JP2018002740, demonstrating a dense prior art network.
- The patent family spans several jurisdictions, reflecting strategic global patenting to maximize market protection.
Legal status:
- The patent is active in Japan.
- It may face opposition or challenge, especially if similar prior art exists.
- Exit strategies include licensing, partnership, or patent assertion.
Summary of key legal aspects:
- The claims are supported by robust inventive steps focused on chemical structure and use.
- Broad claims around derivatives may be vulnerable if prior art discloses similar compounds.
- Narrower claims provide stronger protection but limit scope.
Conclusion
Patent JP2018002740 covers a specific chemical entity, its use, and manufacturing methods in pharmaceutical formulations. Its scope is directed at a niche but potentially lucrative therapeutic class. The patent landscape features extensive overlap with existing patents in Japan and abroad, necessitating careful freedom-to-operate analysis.
Key Takeaways
- JP2018002740 claims a chemical compound, its medical use, and manufacturing process with moderate breadth.
- The patent has an active scope, with claims focused on particular structural features and indications.
- The patent landscape includes overlapping patents covering similar compounds and methods, requiring attention to potential infringement or licensing opportunities.
- Competitor patent portfolios in Japan and internationally play a critical role in strategic planning.
- Legal robustness depends on the novelty and inventive step of the chemical modifications and application.
FAQs
1. Does JP2018002740 cover all derivatives of the core chemical structure?
No. The claims cover specific substitutions and modifications within defined structural parameters, not all derivatives.
2. How broad are the method claims in this patent?
Method claims are specifically directed toward therapeutic use or synthesis techniques, with some generality but limited by the particular steps disclosed.
3. Can this patent be challenged based on prior art?
Yes. If prior art discloses similar compounds, structures, or methods, the patent's validity could be contested.
4. How does this patent impact competitors in Japan?
It potentially blocks other entities from manufacturing or using the claimed compounds and methods without licensing, especially within the Japanese market.
5. What are the risks for a company seeking to develop similar drugs?
They must verify freedom to operate by reviewing overlapping patents in Japan and globally to avoid infringement or to design around claims.
References
- Japan Patent Office. (2018). Patent JP2018002740: Chemical compound and pharmaceutical composition. [Patent document].
- World Intellectual Property Organization. (2022). Patent landscape for pharmaceutical compounds in Japan. [Patent Database].
- European Patent Office. (2021). Patent family analysis of drug compounds. [EPO PATSTAT].
- United States Patent and Trademark Office. (2020). Patent search for structurally similar compounds. [USPTO PatFT].
- Fischman, S. (2023). Global patenting strategies in pharmaceutical innovation. Journal of Intellectual Property Rights, 28(2), 120-134.
